NCT04888390

Brief Summary

Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in diabetes mellitus with heart failure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2021

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 17, 2021

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 17, 2021

Status Verified

May 1, 2021

Enrollment Period

3.7 years

First QC Date

May 5, 2021

Last Update Submit

May 11, 2021

Conditions

Keywords

Heart failureDiabetes mellitusExercise interventionCardiac rehabilitation

Outcome Measures

Primary Outcomes (6)

  • NT-proBNP

    N-terminal pro-brain natriuretic peptide

    Change from baseline (0 week) to mid-intervention (6 weeks)

  • NT-proBNP

    N-terminal pro-brain natriuretic peptide

    Change from baseline (0 week) to post-intervention (12 weeks)

  • NT-proBNP

    N-terminal pro-brain natriuretic peptide

    Change from baseline (0 week) to follow up (24 weeks)

  • Oxygen consumption (VO2)

    Oxygen consumption examined by cardiopulmonary exercise test

    Change from baseline (0 week) to mid-intervention (6 weeks)

  • Oxygen consumption (VO2)

    Oxygen consumption examined by cardiopulmonary exercise test

    Change from baseline (0 week) to post-intervention (12 weeks)

  • Oxygen consumption (VO2)

    Oxygen consumption examined by cardiopulmonary exercise test

    Change from baseline (0 week) to follow up (24 weeks)

Secondary Outcomes (12)

  • Quality of life score (Minnesota Living With Heart Failure Questionnaire)

    Change from baseline (0 week) to mid-intervention (6 weeks)

  • Quality of life score (Minnesota Living With Heart Failure Questionnaire)

    Change from baseline (0 week) to post-intervention (12 weeks)

  • Quality of life score (Minnesota Living With Heart Failure Questionnaire)

    Change from baseline (0 week) to follow up (24 weeks)

  • FEV1/FVC

    Change from baseline (0 week) to mid-intervention (6 weeks)

  • FEV1/FVC

    Change from baseline (0 week) to post-intervention (12 weeks)

  • +7 more secondary outcomes

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group will receive multi-model exercise intervention 2-3 times per week for 3 months.

Behavioral: Muti-model exercise intervention

Usual care group

ACTIVE COMPARATOR

The Usual care group will receive heart failure disease and exercise-related education.

Behavioral: Disease and exercise suggestion

Interventions

The Muti-model exercise intervention include aerobic exercise training by ergometer or treadmill, resistance exercise by using elastic band and flexibility exercise by active stretch. The total training program takes for 60 minutes, 2-3 times per week for 3 months.

Intervention group

The participants will be provided by educational program about heart failure self-care and home-based exercise approach.

Usual care group

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Heart Failure (NYHA I-III) with diabetes mellitus
  • Aged 30-85
  • Mini-mental state examination score \> 25

You may not qualify if:

  • eGFR \< 30mL/min/1.73m2
  • Exercise intervention contraindication of heart failure
  • Pregnancy
  • Uncontrolled disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng Kung University

Tainan, 701, Taiwan

RECRUITING

MeSH Terms

Conditions

Heart FailureDiabetes Mellitus

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Kun-Ling Tsai, Ph.D.

    Department of Physical Therapy, National Cheng Kung University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hsin-Lun Yang, M.S.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The study population will be randomized and separated in two groups, Intervention and Usual care group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 5, 2021

First Posted

May 17, 2021

Study Start

April 20, 2021

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

May 17, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

IPD sharing plan will be decided after summarized data being published.

Locations